Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1990 Sep;71(1):46–51.

Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.

P C McMinn 1, G M Halliday 1, H K Muller 1
PMCID: PMC1384219  PMID: 1698716

Abstract

Dendritic Langerhans' cells (LC), which are essential for the induction of cutaneous immunity, express high concentrations of class II major histocompatibility (MHC) glycoproteins (Ia in the mouse) on their plasma membrane. Application of gliotoxin, a member of the epipolythiodoxopiperazine (ETP) group of fungal metabolites, reduces epidermal LC density and alters their morphology from highly dendritic to a more rounded form. Here we demonstrate that gliotoxin also alters LC function, reducing contact hypersensitivity (CHS) responses due to the development of suppressor cells, and enhancing C57BL tail skin graft survival on BALB/c recipients. The reduction in LC density following gliotoxin application was shown to enhance skin graft survival, by reducing the concentration of Ia antigens within the graft, by using congenic mouse strains: B10.A(2R) x B10.A, differing only at H-2D, and B10.A(2R) x B10.A(4R), differing only at H-2 I-E. Treatment of B10.A(2R) tail skin with gliotoxin for 1 week did not affect its survival when grafted onto H-2D-disparate B10.A mice, whereas, when grafted onto H-2 I-E-disparate B10.A(4R) hosts, the grafts were not only accepted permanently, but induced specific unresponsiveness. It is concluded that gliotoxin has a marked effect on LC function, inhibiting CHS responses by the induction of suppressor cells and prolonging graft survival between H-2-disparate and congenic mouse strains.

Full text

PDF
46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eichner R. D., Al Salami M., Wood P. R., Müllbacher A. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol. 1986;8(7):789–797. doi: 10.1016/0192-0561(86)90016-0. [DOI] [PubMed] [Google Scholar]
  2. Greene M. I., Sy M. S., Kripke M., Benacerraf B. Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6591–6595. doi: 10.1073/pnas.76.12.6591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Halliday G. M., Cavanagh L. L., Muller H. K. Antigen presented in the local lymph node by cells from dimethylbenzanthracene-treated murine epidermis activates suppressor cells. Cell Immunol. 1988 Dec;117(2):289–302. doi: 10.1016/0008-8749(88)90119-0. [DOI] [PubMed] [Google Scholar]
  4. Halliday G. M., Dickinson J. L., Muller H. K. Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate. Immunology. 1989 Jul;67(3):298–302. [PMC free article] [PubMed] [Google Scholar]
  5. Halliday G. M., Knight B. A., Muller H. K. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol. 1986 Jan;114(1):83–89. doi: 10.1111/j.1365-2133.1986.tb02782.x. [DOI] [PubMed] [Google Scholar]
  6. Halliday G. M., MacCarrick G. R., Muller H. K. Tumour promoters but not initiators deplete Langerhans cells from murine epidermis. Br J Cancer. 1987 Sep;56(3):328–330. doi: 10.1038/bjc.1987.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Halliday G. M., Muller H. K. Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen. Cell Immunol. 1986 Apr 15;99(1):220–227. doi: 10.1016/0008-8749(86)90230-3. [DOI] [PubMed] [Google Scholar]
  8. Halliday G. M., Muller H. K. Sensitization through carcinogen-induced Langerhans cell-deficient skin activates specific long-lived suppressor cells for both cellular and humoral immunity. Cell Immunol. 1987 Oct 1;109(1):206–221. doi: 10.1016/0008-8749(87)90305-4. [DOI] [PubMed] [Google Scholar]
  9. Halliday G. M., Odling K. A., Ruby J. C., Muller H. K. Suppressor cell activation and enhanced skin allograft survival after tumor promotor but not initiator induced depletion of cutaneous Langerhans cells. J Invest Dermatol. 1988 Mar;90(3):293–297. doi: 10.1111/1523-1747.ep12456077. [DOI] [PubMed] [Google Scholar]
  10. Klein J. Allograft reaction against H-2-region antigens. Transplant Proc. 1977 Mar;9(1):847–852. [PubMed] [Google Scholar]
  11. Lafferty K. J., Prowse S. J., Simeonovic C. J., Warren H. S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1:143–173. doi: 10.1146/annurev.iy.01.040183.001043. [DOI] [PubMed] [Google Scholar]
  12. Lissing J. R., Tuch B. E., Suranyi M. G. The use of gliotoxin in human fetal pancreas transplantation. Transplant Proc. 1988 Feb;20(1):76–78. [PubMed] [Google Scholar]
  13. Lynch D. H., Gurish M. F., Daynes R. A. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity. J Immunol. 1981 May;126(5):1892–1897. [PubMed] [Google Scholar]
  14. McKenzie I. F., Henning M. M., Morgan G. M. Skin graft enhancement studies with antigenic differences arising from the H-2K, H-2D, and H-2L loci. Transplantation. 1980 Jun;29(6):439–443. doi: 10.1097/00007890-198006000-00002. [DOI] [PubMed] [Google Scholar]
  15. Mitchison N. A. Graft rejection, the histocompatibility complex and the Langerhans' cell. Clin Exp Dermatol. 1979 Dec;4(4):489–493. doi: 10.1111/j.1365-2230.1979.tb01646.x. [DOI] [PubMed] [Google Scholar]
  16. Müllbacher A., Moreland A. F., Waring P., Sjaarda A., Eichner R. D. Prevention of graft-versus-host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire. Transplantation. 1988 Jul;46(1):120–125. doi: 10.1097/00007890-198807000-00022. [DOI] [PubMed] [Google Scholar]
  17. Noonan F. P., De Fabo E. C., Kripke M. L. Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity. Photochem Photobiol. 1981 Dec;34(6):683–689. [PubMed] [Google Scholar]
  18. Nordlund J. J., Ackles A. E., Lerner A. B. The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis. Cell Immunol. 1981 May 1;60(1):50–63. doi: 10.1016/0008-8749(81)90247-1. [DOI] [PubMed] [Google Scholar]
  19. Odling K. A., Halliday G. M., Muller H. K. Effects of low or high doses of short wavelength ultraviolet light (UVB) on Langerhans cells and skin allograft survival. Immunol Cell Biol. 1987 Aug;65(Pt 4):337–343. doi: 10.1038/icb.1987.38. [DOI] [PubMed] [Google Scholar]
  20. Odling K. A., Halliday G. M., Muller H. K. Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene. Immunology. 1987 Nov;62(3):379–385. [PMC free article] [PubMed] [Google Scholar]
  21. Rowden G. The Langerhans cell. Crit Rev Immunol. 1981 Dec;3(2):95–180. [PubMed] [Google Scholar]
  22. Stingl G., Tamaki K., Katz S. I. Origin and function of epidermal Langerhans cells. Immunol Rev. 1980;53:149–174. doi: 10.1111/j.1600-065x.1980.tb01043.x. [DOI] [PubMed] [Google Scholar]
  23. Streilein J. W., Bergstresser P. R. Ia antigens and epidermal Langerhans cells. Transplantation. 1980 Nov;30(5):319–323. [PubMed] [Google Scholar]
  24. Streilein J. W., Lonsberry L. W., Bergstresser P. R. Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med. 1982 Mar 1;155(3):863–871. doi: 10.1084/jem.155.3.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tidman M. J., Wells R. S. Control of plantar blisters in pachyonychia congenita with topical aluminium chloride. Br J Dermatol. 1988 Mar;118(3):451–452. doi: 10.1111/j.1365-2133.1988.tb02447.x. [DOI] [PubMed] [Google Scholar]
  26. Toews G. B., Bergstresser P. R., Streilein J. W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol. 1980 Jan;124(1):445–453. [PubMed] [Google Scholar]
  27. Unanue E. R., Beller D. I., Lu C. Y., Allen P. M. Antigen presentation: comments on its regulation and mechanism. J Immunol. 1984 Jan;132(1):1–5. [PubMed] [Google Scholar]
  28. Waring P., Eichner R. D., Müllbacher A. The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med Res Rev. 1988 Oct-Dec;8(4):499–524. doi: 10.1002/med.2610080404. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES